Trial Profile
Comparative Prospective Randomized Study in Postoperative Cardiac Surgery Patients on Analgesia with Morphine Continuous Infusion or Sublingual Sufentanil (Zalviso®)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Jun 2021
Price :
$35
*
At a glance
- Drugs Sufentanil (Primary) ; Morphine
- Indications Postoperative pain
- Focus Therapeutic Use
- 08 Jun 2021 Status changed from recruiting to completed.
- 17 Aug 2018 New trial record